| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 888,000 | 895,000 | 1,023,009 | 990,379 | | Cost of Revenue | 522,000 | 526,000 | 620,454 | 591,342 | | | Gross Profit | 366,000 | 369,000 | 402,555 | 399,037 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 179,000 | 171,000 | 178,923 | 197,487 | | Non Recurring | 3,000 | 8,000 | 9,495 | 8,723 | | Others | 26,000 | 24,000 | 26,849 | 27,771 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 158,000 | 166,000 | 187,288 | 165,056 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,000) | 5,000 | (106,876) | (10,044) | | Earnings Before Interest And Taxes | 138,000 | 169,000 | 107,578 | 154,763 | | Interest Expense | 24,000 | 27,000 | 31,061 | 55,545 | | Income Before Tax | 114,000 | 142,000 | 76,517 | 99,218 | | Income Tax Expense | 46,000 | 48,000 | 39,753 | 39,102 | | Minority Interest |
-
|
-
| (155) | (249) | | | | Net Income From Continuing Ops | 68,000 | 94,000 | 36,764 | 60,116 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 68,000 | 94,000 | 36,764 | 60,116 | | Preferred Stock And Other Adjustments | 1,000 |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $69,000 | $94,000 | $36,764 | $60,116 |
|
0.20% Nasdaq 
Income Statement
